OBJECTIVE: We investigated the usefulness of perioperative blood glucose control in patients undergoing coronary artery bypass grafting (CABG). METHODS: DM patients were aggressively treated with intensive insulin therapy to achieve a preoperative fasting blood glucose level of 140 mg/dl and a postoperative level of 200 mg/dl. For comparison, patients were divided as follows: (1) DM group vs. non-DM group, and (2) for mean blood glucose level in the intensive care unit (ICU), lower than 200 mg/dl (IL) vs. 200 mg/dl or higher (IH). RESULTS: (1) In the DM group, the amount of insulin (U) used during surgery was greater (P<0.05), and the duration of ICU stay was longer (P<0.05). The incidence of all complications was higher in the DM group (P<0.05). (2) Between the IH group (54) and the IL group (82), the proportion of DM patients was higher in the IH group (75% vs. 38%, P<0.05). In the IH, the duration of ICU stay (P<0.01) was longer, and the incidence of all complications was higher (P<0.05). (3) In the DM group, the incidence of complications tended to be higher in the IH group. The incidence of complications was extremely low in the non-DM group. CONCLUSION: Strict perioperative blood glucose control may help to improve the outcomes of CABG.
OBJECTIVE: We investigated the usefulness of perioperative blood glucose control in patients undergoing coronary artery bypass grafting (CABG). METHODS:DMpatients were aggressively treated with intensive insulin therapy to achieve a preoperative fasting blood glucose level of 140 mg/dl and a postoperative level of 200 mg/dl. For comparison, patients were divided as follows: (1) DM group vs. non-DM group, and (2) for mean blood glucose level in the intensive care unit (ICU), lower than 200 mg/dl (IL) vs. 200 mg/dl or higher (IH). RESULTS: (1) In the DM group, the amount of insulin (U) used during surgery was greater (P<0.05), and the duration of ICU stay was longer (P<0.05). The incidence of all complications was higher in the DM group (P<0.05). (2) Between the IH group (54) and the IL group (82), the proportion of DMpatients was higher in the IH group (75% vs. 38%, P<0.05). In the IH, the duration of ICU stay (P<0.01) was longer, and the incidence of all complications was higher (P<0.05). (3) In the DM group, the incidence of complications tended to be higher in the IH group. The incidence of complications was extremely low in the non-DM group. CONCLUSION: Strict perioperative blood glucose control may help to improve the outcomes of CABG.
Authors: Patrick W Serruys; Andrew T L Ong; Lex A van Herwerden; J Eduardo Sousa; Adib Jatene; Johannes J R M Bonnier; Jacques P M A Schönberger; Nigel Buller; Robert Bonser; Clemens Disco; Bianca Backx; Paul G Hugenholtz; Brian G Firth; Felix Unger Journal: J Am Coll Cardiol Date: 2005-08-16 Impact factor: 24.094
Authors: V H Thourani; W S Weintraub; B Stein; S S Gebhart; J M Craver; E L Jones; R A Guyton Journal: Ann Thorac Surg Date: 1999-04 Impact factor: 4.330
Authors: J Bucerius; J F Gummert; T Walther; N Doll; V Falk; J F Onnasch; M J Barten; F W Mohr Journal: Thorac Cardiovasc Surg Date: 2003-02 Impact factor: 1.827
Authors: Harold L Lazar; Stuart R Chipkin; Carmel A Fitzgerald; Yusheng Bao; Howard Cabral; Carl S Apstein Journal: Circulation Date: 2004-03-08 Impact factor: 29.690
Authors: Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr Journal: J Thorac Cardiovasc Surg Date: 2003-05 Impact factor: 5.209
Authors: K M Detre; P Guo; R Holubkov; R M Califf; G Sopko; R Bach; M M Brooks; M G Bourassa; R J Shemin; A D Rosen; R J Krone; R L Frye; F Feit Journal: Circulation Date: 1999-02-09 Impact factor: 29.690
Authors: Wojciech Szychta; Franciszek Majstrak; Grzegorz Opolski; Krzysztof J Filipiak Journal: Postepy Kardiol Interwencyjnej Date: 2016-08-19 Impact factor: 1.426